Vaxess Technologies raises $50m, rebrands to Terrestrial Bio [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Terrestrial's Series C financing round was led by RA Capital. Venture capital (VC) firms Engine Ventures, GHIC, and SiteGround also participated. Terrestrial's lead product is comprised of a patch resembling an adhesive bandage that is applied with a preloaded applicator and removed after a few minutes. Once applied, each patch delivers bioactive tips into the skin, which dissolve into the body to release their therapeutic payload. According to Terrestrial, the rebrand from Vaxess reflects its strategic focus on “transforming the delivery and accessibility of therapies”. The company plans to start applying its microarray patch (MAP) and applicator platform with glucagon-like peptide-1 receptor agonists (GLP-1RAs). In Terrestrial's recent GLP-1RA human factors study , the majority of participants expressed a preference for the patch applicator over traditional injection devices. “In recent years, it became clear that our company name should more clearly reflect our focus on th
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy? [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk: A Comeback Story In The World's Fastest-Growing Drug Market [Seeking Alpha]Seeking Alpha
- Hims & Hers shifts business model after Novo deal [Yahoo! Finance]Yahoo! Finance
- FDA Approval Of Awiqli Adds New Dimension To Novo Nordisk Story [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S: Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/27/26 - Form 6-K
- 3/27/26 - Form 6-K
- 3/26/26 - Form 6-K
- NVO's page on the SEC website